IRCT20181030041503N1招募中未知
Clinical trial comparing pregnancy rate in transfer of blastocyst vs cleavage stage in assisted reproductive technology
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 40 years（—）
- 性别
- Female
入选标准
- •Uterine with normal cavity
- •Normal res ponder to ovarian stimulation
- •There are at least 5 fresh embryo
- •Sufficient thickness of endometrium in day 12 cycles
排除标准
- •lack of embryo with good quality
- •Endocrine disorder(Hypothyroidism ,diabetes)
- •Poor respond er(less and equal 3 oocyte)
- •Excessive responder to ovarian stimulation (more than 20oocyte)
- •Freeze all of all embryos
- •Refusal to cooperation in the study
- •previous surgery of uterine
- •Recurrent abortion
- •Sever male factor
研究者
相似试验
已完成
不适用
Comparison of pregnancy rate between fresh and frozen embryo transfer cycles in women with endometriosisEndometriosis of ovary.Endometriosis of ovaryIRCT201608171141N21Royan Institute60
进行中（未招募）
不适用
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFEUCTR2013-001105-81-BGActavis Group PTC ehf.766
进行中（未招募）
1 期
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFEUCTR2013-001105-81-CZActavis Group PTC ehf.766
进行中（未招募）
不适用
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.EUCTR2013-001105-81-HUActavis Group PTC ehf.766
进行中（未招募）
1 期
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFEUCTR2013-001105-81-BEActavis Group PTC ehf.766